These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16172858)

  • 1. Lrrk2 pathogenic substitutions in Parkinson's disease.
    Mata IF; Kachergus JM; Taylor JP; Lincoln S; Aasly J; Lynch T; Hulihan MM; Cobb SA; Wu RM; Lu CS; Lahoz C; Wszolek ZK; Farrer MJ
    Neurogenetics; 2005 Dec; 6(4):171-7. PubMed ID: 16172858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.
    Hatano T; Funayama M; Kubo SI; Mata IF; Oji Y; Mori A; Zabetian CP; Waldherr SM; Yoshino H; Oyama G; Shimo Y; Fujimoto KI; Oshima H; Kunii Y; Yabe H; Mizuno Y; Hattori N
    Neurobiol Aging; 2014 Nov; 35(11):2656.e17-2656.e23. PubMed ID: 24973808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 R1441G in Spanish patients with Parkinson's disease.
    Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
    Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.
    Lorenzo-Betancor O; Samaranch L; Ezquerra M; Tolosa E; Lorenzo E; Irigoyen J; Gaig C; Pastor MA; Soto-Ortolaza AI; Ross OA; Rodríguez-Oroz MC; Valldeoriola F; Martí MJ; Luquin MR; Perez-Tur J; Burguera JA; Obeso JA; Pastor P
    Mov Disord; 2012 Jan; 27(1):146-51. PubMed ID: 22038903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.
    Di Fonzo A; Tassorelli C; De Mari M; Chien HF; Ferreira J; Rohé CF; Riboldazzi G; Antonini A; Albani G; Mauro A; Marconi R; Abbruzzese G; Lopiano L; Fincati E; Guidi M; Marini P; Stocchi F; Onofrj M; Toni V; Tinazzi M; Fabbrini G; Lamberti P; Vanacore N; Meco G; Leitner P; Uitti RJ; Wszolek ZK; Gasser T; Simons EJ; Breedveld GJ; Goldwurm S; Pezzoli G; Sampaio C; Barbosa E; Martignoni E; Oostra BA; Bonifati V;
    Eur J Hum Genet; 2006 Mar; 14(3):322-31. PubMed ID: 16333314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 mutations are a common cause of Parkinson's disease in Spain.
    Mata IF; Ross OA; Kachergus J; Huerta C; Ribacoba R; Moris G; Blazquez M; Guisasola LM; Salvador C; Martinez C; Farrer M; Alvarez V
    Eur J Neurol; 2006 Apr; 13(4):391-4. PubMed ID: 16643318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.
    Taylor JP; Hulihan MM; Kachergus JM; Melrose HL; Lincoln SJ; Hinkle KM; Stone JT; Ross OA; Hauser R; Aasly J; Gasser T; Payami H; Wszolek ZK; Farrer MJ
    Neurogenetics; 2007 Apr; 8(2):95-102. PubMed ID: 17225181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.
    Kachergus J; Mata IF; Hulihan M; Taylor JP; Lincoln S; Aasly J; Gibson JM; Ross OA; Lynch T; Wiley J; Payami H; Nutt J; Maraganore DM; Czyzewski K; Styczynska M; Wszolek ZK; Farrer MJ; Toft M
    Am J Hum Genet; 2005 Apr; 76(4):672-80. PubMed ID: 15726496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.
    Ferreira JJ; Guedes LC; Rosa MM; Coelho M; van Doeselaar M; Schweiger D; Di Fonzo A; Oostra BA; Sampaio C; Bonifati V
    Mov Disord; 2007 Jun; 22(8):1194-201. PubMed ID: 17469194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of LRRK2 parkinsonism.
    Haugarvoll K; Wszolek ZK
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S205-8. PubMed ID: 20082991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
    Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
    Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
    Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
    Pankratz N; Pauciulo MW; Elsaesser VE; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Nichols WC;
    Mov Disord; 2006 Dec; 21(12):2257-60. PubMed ID: 17078063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease.
    Lesage S; Condroyer C; Lannuzel A; Lohmann E; Troiano A; Tison F; Damier P; Thobois S; Ouvrard-Hernandez AM; Rivaud-Péchoux S; Brefel-Courbon C; Destée A; Tranchant C; Romana M; Leclere L; Dürr A; Brice A;
    J Med Genet; 2009 Jul; 46(7):458-64. PubMed ID: 19357115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 gene variation and its contribution to Parkinson disease.
    Paisán-Ruiz C
    Hum Mutat; 2009 Aug; 30(8):1153-60. PubMed ID: 19472409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
    Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J
    J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism.
    Ross OA; Spanaki C; Griffith A; Lin CH; Kachergus J; Haugarvoll K; Latsoudis H; Plaitakis A; Ferreira JJ; Sampaio C; Bonifati V; Wu RM; Zabetian CP; Farrer MJ
    Parkinsonism Relat Disord; 2009 Jul; 15(6):466-7. PubMed ID: 18952485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.
    Xiromerisiou G; Hadjigeorgiou GM; Gourbali V; Johnson J; Papakonstantinou I; Papadimitriou A; Singleton AB
    Eur J Neurol; 2007 Jan; 14(1):7-11. PubMed ID: 17222106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.